SIMEONE, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 22.593
EU - Europa 14.955
AS - Asia 14.022
SA - Sud America 3.007
AF - Africa 257
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 34
Totale 54.912
Nazione #
US - Stati Uniti d'America 22.210
CN - Cina 4.724
SG - Singapore 4.375
UA - Ucraina 3.561
PL - Polonia 2.627
BR - Brasile 2.550
IT - Italia 2.465
DE - Germania 2.194
HK - Hong Kong 1.993
FI - Finlandia 1.023
VN - Vietnam 1.017
FR - Francia 742
RU - Federazione Russa 673
TR - Turchia 661
IE - Irlanda 583
GB - Regno Unito 558
IN - India 418
CA - Canada 199
AR - Argentina 175
ID - Indonesia 131
SE - Svezia 129
BD - Bangladesh 122
ZA - Sudafrica 105
MX - Messico 104
IQ - Iraq 90
EC - Ecuador 83
BE - Belgio 77
JP - Giappone 69
NL - Olanda 68
IR - Iran 67
PK - Pakistan 62
SA - Arabia Saudita 56
ES - Italia 55
AT - Austria 52
CO - Colombia 44
VE - Venezuela 44
AU - Australia 38
EU - Europa 34
UZ - Uzbekistan 34
PY - Paraguay 33
MA - Marocco 32
CZ - Repubblica Ceca 29
EG - Egitto 26
KE - Kenya 26
AE - Emirati Arabi Uniti 25
CL - Cile 24
TN - Tunisia 23
UY - Uruguay 22
AZ - Azerbaigian 19
NP - Nepal 19
JM - Giamaica 18
PE - Perù 18
IL - Israele 17
LT - Lituania 15
MY - Malesia 15
DZ - Algeria 14
JO - Giordania 14
TT - Trinidad e Tobago 14
KZ - Kazakistan 13
BO - Bolivia 12
DO - Repubblica Dominicana 10
HN - Honduras 10
MU - Mauritius 10
PA - Panama 10
RO - Romania 10
OM - Oman 9
AL - Albania 8
CH - Svizzera 8
KG - Kirghizistan 8
LV - Lettonia 8
PT - Portogallo 8
KR - Corea 7
NO - Norvegia 7
BY - Bielorussia 6
EE - Estonia 6
ET - Etiopia 6
MK - Macedonia 6
BH - Bahrain 5
CR - Costa Rica 5
LA - Repubblica Popolare Democratica del Laos 5
MD - Moldavia 5
PH - Filippine 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
BB - Barbados 4
BG - Bulgaria 4
DK - Danimarca 4
KH - Cambogia 4
LB - Libano 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
AM - Armenia 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
GE - Georgia 3
GR - Grecia 3
GT - Guatemala 3
Totale 54.870
Città #
Warsaw 2.616
Fairfield 2.582
Jacksonville 2.467
Ashburn 2.074
Hong Kong 1.990
Singapore 1.960
Woodbridge 1.736
Princeton 1.115
Beijing 1.099
Houston 1.057
Cambridge 1.054
Seattle 1.039
Wilmington 983
Ann Arbor 899
Nanjing 731
Chandler 619
Dublin 579
Helsinki 534
Istanbul 513
New York 508
Los Angeles 435
Ho Chi Minh City 316
Nanchang 307
Munich 285
Dearborn 250
Des Moines 246
São Paulo 234
The Dalles 229
Moscow 222
Redondo Beach 214
Buffalo 211
Shenyang 205
Dong Ket 196
Milan 192
Changsha 189
San Diego 161
Hanoi 160
Hebei 152
Shanghai 148
Tianjin 148
Jinan 138
Dallas 132
Brescia 126
Rome 125
Turku 123
Jiaxing 110
San Francisco 110
Rio de Janeiro 95
Kunming 91
Toronto 88
Chicago 84
Santa Clara 83
Verona 75
Brussels 71
Kocaeli 69
Zhengzhou 69
London 67
Guangzhou 65
Jakarta 64
Johannesburg 64
Washington 63
Hangzhou 62
Boardman 58
Nürnberg 57
San Mateo 55
Ardabil 53
Tokyo 53
Belo Horizonte 52
Brooklyn 52
Denver 52
Atlanta 51
Falkenstein 51
Montreal 51
Augusta 50
Monmouth Junction 47
Lanzhou 44
Norwalk 43
Phoenix 42
Brasília 40
Chennai 40
Ningbo 40
Frankfurt am Main 39
Porto Alegre 38
Curitiba 36
Stockholm 35
Da Nang 34
Campinas 33
Düsseldorf 33
Mexico City 32
Nuremberg 32
Poplar 32
Baghdad 31
Boston 31
Leawood 31
Tashkent 31
Ankara 30
Bologna 30
Haikou 30
Lancaster 30
Hefei 28
Totale 34.176
Nome #
Reflusso vescico ureterale nel rene trapiantato 349
INCONTINENZA URINARIA NELL'ANZIANO da Linee guida sull'incontinenza 4° Consultazione internazionale sull'incontinenza- Raccomandazioni ICI 2009 (traduzione in lingua italiana) 349
Complex Relationships between Occupation, Environment, DNA Adducts, Genetic Polymorphisms and Bladder Cancer in a Case-Control Study Using a Structural Equation Modeling. 283
Usefulness of sacral nerve modulation in a series of multiple sclerosis patients with bladder dysfunction 281
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 279
Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: Is combination therapy better than monotherapy 275
Laparoscopic and robotic ureteral stenosis repair: a multi-institutional experience with a long-term follow-up 272
CALCOLOSI MOLLE CALICEALE: UN CASO DI DIFFICILE DIAGNOSI 266
REIMPIANTO URETERALE LAPAROSCOPICO ROBOT-ASSISTED PER REFLUSSO VESCICO URETERALE RECIDIVO A INFILTRAZIONE CON MACROPLASTIQUE 260
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 230
Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma 229
External validation of the preoperative Karakiewicz nomogram in a large multicentre series of patients with renal cell carcinoma 220
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 220
[ProACT (Adjustable Continence Therapy) implants in case of failure of other techniques for urinary incontinence]. 219
Robot-assisted Partial Nephrectomy and Bilateral Pyelolithotomy in Ectopic Pelvic Kidneys 211
The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy 210
Caratterizzazione dei linfonodi retroperitoneali in risonanza magnetica con mezzo di contrasto linfonodo specifico (AMI227): confronto con l'istologia 205
Pros-IT CNR: an Italian prostate cancer monitoring project 205
Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration 203
Outcomes of Partial and Radical Nephrectomy in Octogenarians – A Multicenter International Study (Resurge) 203
Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years 187
How to improve patient selection for neoadjuvant chemotherapy in bladder cancer patients candidate for radical cystectomy and pelvic lymph node dissection 186
Robotic partial nephrectomy versus radical nephrectomy in elderly patients with large renal masses 185
[Acetylcholine induces human detrusor muscle cell proliferation: molecular and pharmacological characterization.] 183
Long-term Prognostic Impact of Chromosome Abnormalities in Clear Cell Renal Cell Carcinoma 180
I recettori muscarinici stimolano la proliferazione di leiomiociti derivati da muscolo detrusore umano 177
Inhibition of Survivin Is Associated with Zoledronic Acid-induced Apoptosis of Prostate Cancer Cells 176
OUTCOMES OF PREVENTIVE VS DELAYED LIGATION OF DORSAL VASCULAR COMPLEX DURING RARP: PRELIMINARY RESULTS OF A RANDOMIZED TRIAL 172
The Simplified PADUA REnal (SPARE) nephrometry system: a novel classification of parenchymal renal tumours suitable for partial nephrectomy 172
Different muscarinic receptor subtypes modulate proliferation of primary human detrusor smooth muscle cells via Akt/PI3K and map kinases. 171
Biological bases of radical prostatectomy in the management of prostate cancer patients with oligometastatic disease 169
18F-FDG PET/CT in a Patient Affected by Renal Collecting Duct (Bellini) Carcinoma 167
Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma 167
DISCRIMINATION ABILITY OF THE SURFACE-INTERMEDIATE-BASE MARGIN (SIB) SCORE: AN EXTERNAL HISTOPATHOLOGICAL EVALUATION 167
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 167
[Ductal carcinoma of the prostate: impact on survival and therapeutic controversies of a rare tumor]. 164
[Insignificant prostate cancer: charateristics and predictive factors]. 164
CAVECTOMIA PER INFILTRAZIONE NEOPLASTICA DA NEOPLASIA RENALE PARENCHIMALE DESTRA 164
Approccio anatomo-clinico alla patologia della prostata 163
[High-intensity focused ultrasound (HIFU): our experience in the treatment of prostate cancer relapsing after radiotherapy]. 163
Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset 163
Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: Are further improvements needed? 163
Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: A single-center retrospective study. 162
Venous tumor thrombus consistency is not predictive of survival in patients with renal cell carcinoma: A retrospective study of 147 patients 162
Features of Ipsilateral Renal Recurrences After Partial Nephrectomy: A Proposal of a Pathogenetic Classification 161
Robotic versus other nephroureterectomy techniques: a systematic review and meta-analysis of over 87,000 cases 161
External histopathological validation of the surface-intermediate-base margin score 161
MUSCARINIC RECEPTORS STIMULATE CELL PROLIFERATION IN THE HUMAN UROTHELIUM-DERIVED CELL LINE UROtsa 160
[Differences in morbidity of neobladder versus ileal conduit: a matched pair analysis on 134 patients] 160
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 159
Impact of Tumor Size on Cancer-Specific Mortality Rate after Local Tumor Ablation in T1a Renal-Cell Carcinoma 159
PATHOGENESIS, FEATURES AND PROGNOSIS OF RENAL RELAPSE AFTER PARTIAL NEPHRECTOMY 159
Prognostic factors in a large multi-institutional series of papillary renal cell carcinoma. 157
PATHOGENESIS, FEATURES AND PROGNOSIS OF RENAL RELAPSE AFTER PARTIAL NEPHRECTOMY 157
MP34-09 IS A DELAY IN THE TIMING OF RADICAL CYSTECTOMY REALLY DETRIMENTAL? A RETROSPECTIVE STUDY ON A SINGLE CENTRE COHORT 157
TERAPIA ENDOCAVITARIA DI SECONDA LINEA CON GEMCITABINA NELLA NEOPLASIA VESCICALE NON MUSCOLO INVASIVA RECIDIVA AD ALTO RISCHIO 156
Serum vitamin D and prostate cancer prognosis: The story continues 155
VENOUS TUMOR THROMBUS CONSISTENCY IS NOT PREDICTIVE OF SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA: A RETROSPECTIVE STUDY ON 147 PATIENTS 155
Surgically-induced hypertension and cardiovascular morbidity following treatment for localized kidney cancer: the impact of nephrons loss 154
Predictors of the Transition from Off to On Clamp Approach during Ongoing Robotic Partial Nephrectomy: Data from the CLOCK Randomized Clinical Trial 154
Prediction tools in non-muscle invasive bladder cancer 154
Features, risk factors and clinical outcome of "very late" recurrences after surgery for localized renal carcinoma: A retrospective evaluation of a cohort with a minimum of 10 years of follow up 153
End-Stage Renal Disease After Renal Surgery in Patients with Normal Preoperative Kidney Function: Balancing Surgical Strategy and Individual Disorders at Baseline 153
Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome 153
Nephron-Sparing Surgery versus Radical Nephrectomy in the Treatment of Intracapsular Renal Cell Carcinoma up to 7 cm 153
[Sliding-clip robotic nephropexy]. 152
A SNAPSHOT OF NEPHRON SPARING SURGERY IN ITALY: A PROSPECTIVE, MULTICENTER REPORT ON CLINICAL AND PERIOPERATIVE OUTCOMES (THE RECORD 1 PROJECT) 152
Comparison of Perioperative Morbidity of Radical Cystectomy with Neobladder Versus Ileal Conduit: A Matched Pair Analysis of 170 Patients 151
A snapshot of nephron-sparing surgery in Italy: A prospective, multicenter report on clinical and perioperative outcomes (the RECORd 1 project) 149
Conditional survival of patients with nonmetastatic renal cell carcinoma: How cancer-specific mortality changes after nephrectomy 149
Standard vs delayed ligature of the dorsal vascular complex during robot-assisted radical prostatectomy: results from a randomized controlled trial 149
Alpha1 adrenoceptor subtypes in human urinary bladder: sex and regional comparison. 148
Role of F18-FDG-PET/CT in restaging patients affected by renal carcinoma 148
Renal Function Impairment Below Safety Limits Correlates With Cancer-specific Mortality in Localized Renal Cell Carcinoma: Results From a Single-center Study 148
Reply by Authors 148
TRATTAMENTO CON EMBOLIZZAZIONE SUPERSELETTIVA DEL PRIAPISMO AD ALTO FLUSSO DA FISTOLA ARTERO-CAVERNOSA 147
[Intrinsic ureteral endometriosis: description of a striking instance.] 147
The R.E.N.A.L. Nephrometric Nomogram Cannot Accurately Predict Malignancy or Aggressiveness of Small Renal Masses Amenable to Partial Nephrectomy. 147
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients 147
Perioperative Outcomes of Open, Laparoscopic, and Robotic Partial Nephrectomy: A Prospective Multicenter Observational Study (The RECORd 2 Project) 146
Holographic Reconstructions for Preoperative Planning before Partial Nephrectomy: A Head-to-Head Comparison with Standard CT Scan 146
DRENAGGIO PERCUTANEO TRANSPERINEALE ECOGUIDATO DEGLI ASCESSI PROSTATICI Transperitoneal percutaneous echo-guided drainage of prostatic abscesses 145
The follow-up management of non-metastatic renal cell carcinoma: Definition of a surveillance protocol 145
A prospective, multicenter evaluation of predictive factors for positive surgical margins after nephron-sparing surgery for renal cell carcinoma: The record1 italian project 143
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails 143
VARIATIONS IN RENAL CORTEX VOLUMES BEFORE AND AFTER PARTIAL NEPHRECTOMY: A PILOT STUDY ON 30 CASES 142
Partial Nephrectomy in Clinical T1b Renal Tumors: Multicenter Comparative Study of Open, Laparoscopic and Robot-assisted Approach (the RECORd Project) 141
Predictive Value of Nephrometry Scores in Nephron-sparing Surgery: A Systematic Review and Meta-analysis 140
Histological variants in non-muscle invasive bladder cancer 140
Riparazione di fistola vescico-rettale secondo la tecnica di york mason 139
[Renal cell carcinoma associated with incidental presentation of renal artery aneurysm: surgical management.] 139
Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series 139
Analysis of radical cystectomy and urinary diversion complications with the Clavien classification system in an Italian real life cohort. 139
DISCRIMINATION ABILITY OF TH SURFACE-INTERMEDIATE-BASE MARGIN :(SIB) SCORE: AN EXTERNAL HISTOPATHOLOGICAL EVALUATION 139
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 139
Minimally Invasive Radical Prostatectomy after Previous Bladder Outlet Surgery: A Systematic Review and Pooled Analysis of Comparative Studies 139
Adherence to the EAU guidelines on Penile Cancer Treatment: European, multicentre, retrospective study 138
LA DIFFERENZIAZIONE SARCOMATOIDE INFLUENZA NEGATIVAMENTE LA PROGNOSI NEI PAZIENTI AFFETTI DA CARCINOMA A CELLULE RENALI INDIPENDENTEMENTE DALL'ISTOTIPO 137
A multicentre matched-pair analysis comparing robot-assisted versus open partial nephrectomy. 137
Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study 137
Totale 17.389
Categoria #
all - tutte 264.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 264.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.930 0 0 0 0 0 1.071 377 1.136 1.070 964 860 452
2021/20224.045 293 789 78 243 70 169 134 315 223 522 312 897
2022/20232.664 600 58 77 102 178 804 20 205 299 36 147 138
2023/20243.980 185 71 243 412 186 666 137 127 1.137 89 64 663
2024/20258.455 81 55 29 1.182 912 759 821 233 880 650 1.779 1.074
2025/20269.960 1.602 2.420 1.404 2.782 1.617 135 0 0 0 0 0 0
Totale 55.671